In individuals for whom VMAT2 inhibitors are contraindicated, such as those with depression, or when VMAT2 inhibitors are unable to adequately control symptoms, antipsychotic drugs are frequently recommended for chorea (Brusa et al. 2009). This evidence concerns the gene SLC18A2 and depressive disorder.